Ethical and legal problems of commodification of biomaterials in the development of genomics and genomic medicine
https://doi.org/10.25557/2073-7998.2020.10.81-83
Abstract
The article considers a number of ethical and legal problems of commodification of biomaterials in the development of genomics and genomic medicine. It is shown that biomaterials in the modern world are considered as objects of property and patent law and become a source of profit. Often this leads to the appearance of incidents related to the protection of the rights of the individual, which is the source of origin of biomaterials. The thesis is put forward that the situation associated with the circulation of biomaterials is reflected in various modes of relations between the individual, science and society, with the articulation of the priority of a personal or public good characteristic of each of them.
References
1. Попова О.В. Человек, его цена и ценность: к проблеме коммодификации тела в научном познании. Эпистемология и философия науки. 2016; 49(3): 140-157.
2. Skloot R. Taking the Least of You. New York Times, 16.04.2006. URL: http://www.nytimes.com/2006/04/16/magazine/16tissue.
3. Прецеденты Европейского Суда по правам человека. 2015; 12 (24):42-116.
4. Ксенофонтова Д.С. Правовые основы генной терапии: в поисках баланса интересов. LEX RUSSIA. 2019;(6):143-152.
5. Popova O.V., Savvina O.V. Ethical issues of gamete donation: body commodification and transformation of family relations. Вестник Российского университета дружбы народов. Серия: Философия. 2018; 22(3): 310-318. doi: 10.22363/2313-2302-2018-22-3-310-318.
Review
For citations:
Popova O.V. Ethical and legal problems of commodification of biomaterials in the development of genomics and genomic medicine. Medical Genetics. 2020;19(10):81-83. (In Russ.) https://doi.org/10.25557/2073-7998.2020.10.81-83
Views:
481
Email this article 